Breaking News Instant updates and real-time market news.

ENR

Energizer

$43.64

-0.33 (-0.75%)

, BRK.A

Berkshire Hathaway

$311,881.00

1035.99 (0.33%)

17:13
09/30/19
09/30
17:13
09/30/19
17:13

Energizer sues Duracell, alleges 'Optimum' claims misleading, Reuters says

Energizer Holdings (ENR) is suing Duracell, a unit of Berkshire Hathaway (BRK.A), accusing the battery maker of misleading consumers by implying that its new "Optimum" AA and AAA batteries are more powerful and longer-lasting than all competing batteries, Reuters' Jonathan Stempel reports. Energizer alleges that Duracell engaged in false advertising for the product with packaging that said its batteries offer "extra life" and "extra power," Stempel says. According to Energizer, however, it is only the "mice-type" fine print that buyers learn that Optimum may outperform Duracell's own Coppertop batteries, not rival batteries, and only in certain devices, the author notes. Reference Link

ENR

Energizer

$43.64

-0.33 (-0.75%)

BRK.A

Berkshire Hathaway

$311,881.00

1035.99 (0.33%)

BRK.B

Berkshire Hathaway

$208.03

0.61 (0.29%)

ENR Energizer
$43.64

-0.33 (-0.75%)

08/22/19
UBSW
08/22/19
UPGRADE
UBSW
Buy
Energizer upgraded to Buy from Neutral at UBS
08/22/19
UBSW
08/22/19
UPGRADE
Target $46
UBSW
Buy
Energizer upgraded to Buy from Neutral at UBS
UBS analyst Steven Strycula upgraded Energizer to Buy but also lowered his price target to $46 from $50. The analyst notes that the stock has lost 45% of its market cap as a result of the initial integration challenges and higher leverage, but contends that at 9.5-times expected forward EBITDA, he sees the "bear case" being priced in.
08/22/19
08/22/19
UPGRADE

Fly Intel: Top five analyst upgrades
Catch up on today's top five analyst upgrades with this list compiled by The Fly: 1. Target (TGT) upgraded to Buy from Neutral at Citi with analyst Paul Lejuez saying he wants to catch the next 20% move up, which he believes will occur as the company continues to prove it is a "winner" in the current retail landscape. 2. Wayfair (W) upgraded to Buy from Hold at Stifel with analyst Scott Devitt saying the 12% decline in the stock price since the company's posted its Q2 results has created a compelling entry point. 3. Energizer (ENR) upgraded to Buy from Neutral at UBS with analyst Steven Strycula saying the stock has lost 45% of its market cap as a result of the initial integration challenges and higher leverage, but contends that at 9.5-times expected forward EBITDA, he sees the "bear case" being priced in. 4. Etsy (ETSY) upgraded to Buy from Hold at Stifel with analyst Scott Devitt saying the 20% decline in the stock price since the company's last earnings report has made its valuation more compelling. 5. Cerner (CERN) upgraded to Buy from Hold at Argus with analyst Jasper Hellweg saying the company is well positioned for growth having just completed its "self-described 'investment year'." This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
09/09/19
BOFA
09/09/19
UPGRADE
Target $48
BOFA
Buy
Energizer upgraded two notches to Buy from Underperform at BofA/Merrill
BofA/Merrill analyst Olivia Tong issued a double-upgrade of Energizer to Buy from Underperform with a price target of $48, modeling an earnings multiple of 14-times expected 2020 EPS vs. 11-times prior. The analyst notes that her prior rating assumed a longer fix to the company's Auto Care business challenges and a "more onerous" than priced in battery cannibalization. Tong adds that while the company's integration of the recently acquired assets may lead to some near-term volatility, she is confident based on the management's turnaround track record. With Energizer down 40% over the past year and the risks now "known", the analyst contends that the double-upgrade is warranted.
BRK.A Berkshire Hathaway
$311,881.00

1035.99 (0.33%)

11/15/18
11/15/18
NO CHANGE

Morgan Stanley says 13F a 'clear signal' of value Buffett sees in financials
Following the release last night of 13F filings detailing the holdings of large investors, including Berkshire Hathaway (BRK.A), Morgan Stanley analyst Kai Pan noted that the filing from Warren Buffett's Berkshire revealed increased stakes in Bank of America (BAC), U.S. Bancorp (USB) and Goldman Sachs (GS) along with new stakes in JPMorgan (JPM), PNC Financial (PNC) and Travelers (TRV). The analyst sees these investments, along with the fact that Berkshire's s financial holdings stood at 46% of its overall $203B equity portfolio as of quarter end, as a "clear signal" of the value that Buffett sees in financials, Pan tells investors. He adds that he views Buffett's new stake in Oracle (ORCL) as another "notable" new purchase.
04/09/19
KEYB
04/09/19
NO CHANGE
Target $235
KEYB
Overweight
Workday wins deal from Berkshire Hathaway's Geico, says KeyBanc
KeyBanc analyst Brent Bracelin reported that he found a recent job posting indicating that Geico, a subsidiary of Berkshire Hathaway (BRK.A), plans to implement Workday (WDAY) Financials as its new ERP system. He view the Geico win, which also includes the use of Workday's Adaptive Insights planning software, as further validation of the increasing cloud financial momentum at the company. The analyst, who sees share gains across both HCM and ERP as the primary drivers of upside for Workday, has an Overweight rating and $235 price target on the shares.
04/24/19
BOFA
04/24/19
NO CHANGE
BOFA
PG&E deal talks report could drive renewed interest, says BofA/Merrill
BofA Merrill Lynch analyst Julien Dumoulin-Smith noted that SparkSpread reported that Berkshire Hathaway Energy (BRK.A) was in talks to acquire bankrupt PG&E (PCG). However, CNBC subsequently reported that Berkshire had no interest, citing direct conversations with Warren Buffett, and a spokesperson also noted the company is not in talks with PG&E, noted the analyst. Still, he thinks headlines regarding the Berkshire interest could help drive renewed interest in PG&E from other large-cap entities, adding that "for all of the same reasons why we see credibility to a potential Berkshire bid, much of the same applies to any other large buyer." Dumoulin-Smith keeps No Rating on PG&E shares given ongoing Chapter 11 proceedings.
06/19/19
SBSH
06/19/19
NO CHANGE
SBSH
Axalta Coating under pressure to deliver on M&A, says Citi
Citi analyst P.J. Juvekar said Axalta is under increased pressure "to deliver on M&A now or risk its credibility" after the company announced it is exploring strategic options again after going through the same process in 2017. Previously the company had M&A negotiations with AkzoNobel (AKZOY) and briefly with Nippon Paints, though neither reached a deal, and this time it could approach new players like Berkshire Hathaway (BRK.A), which already owns roughly 10% of the company, or Sherwin-Williams (SHW), contends Juvekar. Axalta does not have architectural paint, which trades at high multiples compared to industrial paint, and he thinks a multiple range of 12x-13x, equating to a stock price in the mid-to-high $30 range, is possible in a deal, though "there is no guarantee that a deal would happen," Juvekar stated in a note to investor before the open.
BRK.B Berkshire Hathaway
$208.03

0.61 (0.29%)

10/17/18
JPMS
10/17/18
NO CHANGE
Target $375000
JPMS
Overweight
Berkshire shares are undervalued on look-through earnings, says JPMorgan
JPMorgan analyst Sarah DeWitt views Berkshire Hathaway as one of the best value plays in her coverage group. Although the stock appears more expensive than the S&P 500 at 20 times 2019 estimated earnings, reported earnings ignore the company's "massive" equity portfolio of nearly $200B, DeWitt tells investors in a research note. The analyst thinks a better measure is look-through earnings, which she notes is the one Warren Buffett endorses and includes Berkshire's share of retained earnings of major investees that are not reflected in GAAP earnings. On this basis, Berkshire trades at 13.6 times estimated 2019 look-through earnings, near the all-time historical low for price-to-look-through earnings ratio and a significant discount to the S&P 500 at 16 times, the analyst says. She thinks Berkshire should trade at least in line with the historical median on look-through earnings of 17 times, which would imply 25% upside. The analyst keeps Overweight rating on both of Berkshire's share classes. DeWitt has a $375,000 price target for the class A shares (BRK.A) and $250 target for the class B shares (BRK.B).

TODAY'S FREE FLY STORIES

SALRF

Salmar

$0.00

(0.00%)

05:16
11/15/19
11/15
05:16
11/15/19
05:16
Upgrade
Salmar rating change  »

Salmar upgraded to Hold…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CNP

CenterPoint Energy

$26.68

-1.42 (-5.05%)

05:14
11/15/19
11/15
05:14
11/15/19
05:14
Downgrade
CenterPoint Energy rating change  »

CenterPoint Energy…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

DDAIF

Daimler AG

$0.00

(0.00%)

05:13
11/15/19
11/15
05:13
11/15/19
05:13
Downgrade
Daimler AG rating change  »

Daimler AG downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SWAV

ShockWave Medical

$36.47

1.38 (3.93%)

05:11
11/15/19
11/15
05:11
11/15/19
05:11
Syndicate
ShockWave Medical 2.482M share Secondary priced at $36.25 »

The deal size was…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 15

    Nov

05:10
11/15/19
11/15
05:10
11/15/19
05:10
General news
FX Action: The yen is trading softer »

FX Action: The yen is…

BGNE

BeiGene

$195.90

-1.25 (-0.63%)

05:09
11/15/19
11/15
05:09
11/15/19
05:09
Recommendations
BeiGene analyst commentary  »

BeiGene price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 07

    Dec

  • 27

    Feb

NXTC

NextCure

$38.60

0.85 (2.25%)

05:09
11/15/19
11/15
05:09
11/15/19
05:09
Syndicate
NextCure 4.08M share Secondary priced at $36.75 »

The deal size was…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 15

    Nov

AAPL

Apple

$262.66

-1.86 (-0.70%)

05:05
11/15/19
11/15
05:05
11/15/19
05:05
Recommendations
Apple price target raised to $290 from $270 at Piper Jaffray »

Piper Jaffray analyst…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

QCOM

Qualcomm

$90.48

0.03 (0.03%)

, AAPL

Apple

$262.66

-1.86 (-0.70%)

04:59
11/15/19
11/15
04:59
11/15/19
04:59
Upgrade
Qualcomm upgraded to Buy from Neutral at Mizuho »

Mizuho analyst Vijay…

QCOM

Qualcomm

$90.48

0.03 (0.03%)

AAPL

Apple

$262.66

-1.86 (-0.70%)

SSNLF

Samsung

$0.00

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Nov

NUE

Nucor

$54.49

-0.2 (-0.37%)

04:55
11/15/19
11/15
04:55
11/15/19
04:55
Conference/Events
Nucor management to meet with KeyBanc »

Management participates…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 15

    Nov

INS

Intelligent Systems

$42.26

-0.34 (-0.80%)

04:55
11/15/19
11/15
04:55
11/15/19
04:55
Conference/Events
Intelligent Systems management to meet with Sidoti »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 15

    Nov

EXPI

eXp World Holdings

$9.97

-0.08 (-0.80%)

04:55
11/15/19
11/15
04:55
11/15/19
04:55
Conference/Events
eXp World Holdings management to meet with DA Davidson »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 15

    Nov

GSHD

Goosehead Insurance

$44.75

0.02 (0.04%)

04:55
11/15/19
11/15
04:55
11/15/19
04:55
Conference/Events
Goosehead Insurance management to meet with William Blair »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 15

    Nov

  • 03

    Dec

04:55
11/15/19
11/15
04:55
11/15/19
04:55
General news
Industrial Production Capacity Utilization Rate to be reported at 09:15 »

October Industrial…

04:55
11/15/19
11/15
04:55
11/15/19
04:55
General news
Business Inventories to be reported at 10:00 »

September Business…

04:55
11/15/19
11/15
04:55
11/15/19
04:55
Conference/Events
CLSA to hold a forum »

22nd CLSA India Forum…

04:55
11/15/19
11/15
04:55
11/15/19
04:55
General news
Breaking General news story  »

Week of 11/15…

TRGP

Targa Resources

$38.03

-0.28 (-0.73%)

04:55
11/15/19
11/15
04:55
11/15/19
04:55
Conference/Events
Targa Resources management to meet with RBC Capital »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 15

    Nov

UBX

Unity Biotechnology

$6.30

-0.26 (-3.96%)

04:55
11/15/19
11/15
04:55
11/15/19
04:55
Conference/Events
Unity Biotechnology management to meet with Mizuho »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 15

    Nov

  • 13

    Dec

CTSO

CytoSorbents

$4.24

-0.2 (-4.50%)

04:55
11/15/19
11/15
04:55
11/15/19
04:55
Conference/Events
CytoSorbents management to meet with B. Riley FBR »

Meeting to be held in New…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 15

    Nov

FTNT

Fortinet

$100.07

0.38 (0.38%)

04:55
11/15/19
11/15
04:55
11/15/19
04:55
Conference/Events
Fortinet management to meet with MKM Partners »

Meeting to be held in New…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 15

    Nov

  • 18

    Nov

  • 19

    Nov

  • 05

    Dec

  • 06

    Dec

  • 09

    Dec

  • 12

    Dec

LNDC

Landec

$11.05

0.195 (1.80%)

04:55
11/15/19
11/15
04:55
11/15/19
04:55
Conference/Events
Landec management to meet with DA Davidson »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 15

    Nov

  • 15

    Nov

SPR

Spirit AeroSystems

$89.60

0.31 (0.35%)

04:55
11/15/19
11/15
04:55
11/15/19
04:55
Conference/Events
Spirit AeroSystems management to meet with Jefferies »

Meeting to be held in San…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 15

    Nov

04:55
11/15/19
11/15
04:55
11/15/19
04:55
Conference/Events
Wolfe Research tech strategist to hold analyst/industry webcast »

Tech Strategist…

DTIL

Precision BioSciences

$11.80

2.33 (24.60%)

04:55
11/15/19
11/15
04:55
11/15/19
04:55
Conference/Events
Precision BioSciences participates in a conference call with BTIG »

Conference call with…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 15

    Nov

  • 07

    Dec

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.